Suppr超能文献

广谱 Hemp 提取物对 Sprague Dawley 大鼠束缚应激诱导模型神经行为活动的影响。

Effect of Broad-Spectrum Hemp Extract on Neurobehavioral Activity on the Immobilization Stress-Induced Model in Sprague Dawley Rats.

机构信息

Compliance and Operations (Toxicology), Vedic Lifesciences Pvt. Ltd., Mumbai, India.

HempRise, 285 Paul Garrett Avenue, Jeffersonville, IN 47130, USA.

出版信息

ScientificWorldJournal. 2023 Jun 10;2023:3425576. doi: 10.1155/2023/3425576. eCollection 2023.

Abstract

BACKGROUND

Broad-spectrum hemp extract is expected to be a promising new intervention for managing stress and anxiety. Research has shown that the cannabinoids found in , such as cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabigerol (CBG), possess anxiolytic properties that can positively impact mood and stress.

METHODS

In the current study, a broad-spectrum, nondetectable THC hemp extract with other minor cannabinoids (broad-spectrum hemp extract) was administered at 28 mg/kg·bw to evaluate its anxiolytic properties. This was performed using various behavioural models and biomarkers for oxidative stress. In addition, a 300 mg/kg·bw of Ashwagandha root extract was also incorporated to compare its effects on relieving stress and anxiety.

RESULTS

The decreased levels of lipid peroxidation were measured in broad-spectrum hemp extract (36 nmol/ml), Ashwagandha (37 nmol/ml), and induction control (49 nmol/ml) treated groups of animals. The levels of 2-AG decreased in the broad-spectrum hemp extract (1.5 ng/ml), Ashwagandha (1.2 ng/ml), and induction control (2.3 ng/ml) treated groups of animals. The levels of FAAH decreased in broad-spectrum hemp extract (1.6 ng/ml), Ashwagandha (1.7 ng/ml), and induction control (1.9 ng/ml) treated groups of animals. The levels of catalase increased in broad-spectrum hemp extract (35 ng/ml), Ashwagandha (37 ng/ml), and induction control (17 ng/ml) treated groups of animals. Similarly, increased levels of glutathione were found in broad-spectrum hemp extract (30 ng/ml), Ashwagandha (27 ng/ml), and induction control (16 ng/ml) treated groups of animals.

CONCLUSION

Based on the results of this study, it can be concluded that broad-spectrum hemp extract inhibited the biomarkers for oxidative stress. Also, certain behavioural parameters showed improvements with respect to both the ingredient administered groups.

摘要

背景

广谱大麻素提取物有望成为管理压力和焦虑的一种有前途的新干预手段。研究表明,存在于大麻中的大麻素,如大麻二酚(CBD)、四氢大麻酚(THC)和大麻萜酚(CBG),具有抗焦虑特性,可以积极影响情绪和压力。

方法

在目前的研究中,给予 28mg/kg·bw 的广谱、无法检测到 THC 的大麻素提取物(广谱大麻素提取物),以评估其抗焦虑特性。这是通过各种行为模型和氧化应激生物标志物来完成的。此外,还加入了 300mg/kg·bw 的 Ashwagandha 根提取物,以比较其缓解压力和焦虑的效果。

结果

在广谱大麻素提取物(36nmol/ml)、Ashwagandha(37nmol/ml)和诱导对照组(49nmol/ml)处理的动物组中,脂质过氧化水平降低。2-AG 水平在广谱大麻素提取物(1.5ng/ml)、Ashwagandha(1.2ng/ml)和诱导对照组(2.3ng/ml)处理的动物组中降低。FAAH 水平在广谱大麻素提取物(1.6ng/ml)、Ashwagandha(1.7ng/ml)和诱导对照组(1.9ng/ml)处理的动物组中降低。在广谱大麻素提取物(35ng/ml)、Ashwagandha(37ng/ml)和诱导对照组(17ng/ml)处理的动物组中,过氧化氢酶水平增加。同样,在广谱大麻素提取物(30ng/ml)、Ashwagandha(27ng/ml)和诱导对照组(16ng/ml)处理的动物组中,谷胱甘肽水平增加。

结论

根据本研究的结果,可以得出结论,广谱大麻素提取物抑制了氧化应激的生物标志物。此外,某些行为参数在给予的成分组中均有所改善。

相似文献

1
Effect of Broad-Spectrum Hemp Extract on Neurobehavioral Activity on the Immobilization Stress-Induced Model in Sprague Dawley Rats.
ScientificWorldJournal. 2023 Jun 10;2023:3425576. doi: 10.1155/2023/3425576. eCollection 2023.
2
Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
Anal Chem. 2020 Jun 2;92(11):7733-7737. doi: 10.1021/acs.analchem.0c00828. Epub 2020 May 21.
4
6
Oral CBD-rich hemp extract modulates sterile inflammation in female and male rats.
Front Physiol. 2023 May 18;14:1112906. doi: 10.3389/fphys.2023.1112906. eCollection 2023.
9
Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids.
Toxicology. 2024 Aug;506:153885. doi: 10.1016/j.tox.2024.153885. Epub 2024 Jul 14.

引用本文的文献

1
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs.
Drug Des Devel Ther. 2024 Jun 11;18:2143-2167. doi: 10.2147/DDDT.S462785. eCollection 2024.

本文引用的文献

2
Molecular Mechanism and Cannabinoid Pharmacology.
Handb Exp Pharmacol. 2020;258:323-353. doi: 10.1007/164_2019_298.
3
Use of cannabidiol in anxiety and anxiety-related disorders.
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):253-261. doi: 10.1016/j.japh.2019.11.008. Epub 2019 Dec 19.
4
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.
5
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.
Pain Ther. 2019 Jun;8(1):41-51. doi: 10.1007/s40122-019-0114-4. Epub 2019 Feb 5.
6
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.
Alcohol Clin Exp Res. 2019 Apr;43(4):550-563. doi: 10.1111/acer.13964. Epub 2019 Feb 19.
7
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041.
8
The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior.
Methods Mol Biol. 2019;1916:99-103. doi: 10.1007/978-1-4939-8994-2_9.
9
Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
Crit Rev Eukaryot Gene Expr. 2018;28(1):73-86. doi: 10.1615/CritRevEukaryotGeneExpr.2018021528.
10
The impact of stress on body function: A review.
EXCLI J. 2017 Jul 21;16:1057-1072. doi: 10.17179/excli2017-480. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验